Transforming e-Learning in Oncology and Urology, ArcheMedX Extends Partnership with AcademicCME and Elsevier
Following the success of their first ArcheViewer-powered educational series in Multiple Sclerosis, AcademicCME and Elsevier have expanded their collaboration with ArcheMedX to launch e-learning initiatives in Non-Small Cell Lung Cancer and Overactive Bladder Disease.
Charlottesville, VA (May 14th, 2014) ArcheMedX announced today, in collaboration with Elsevier’s Office of Continuing Medical Education (EOCME) and AcademicCME, the launch of two innovative continuing medical education (CME) programs powered by the ArcheViewer, a data-driven, e-learning architecture. These new educational programs deliver a more interactive learning experience around recent science, clinical trial data, and best practices when creating individualized treatment plans for patients diagnosed with Overactive Bladder Disease or Non-Small Cell Lung Cancer.
The launch of these educational series by AcademicCME, ArcheMedX, and Elsevier, follows the success of their first collaboration, “Improving Patient Outcomes in Multiple Sclerosis”. Since launching in September 2013, this innovative e-learning initiative continues to demonstrate meaningful and significant improvement in learning and competence among the clinicians who participate in the four-part mini-curriculum.
“The success of our first educational series in partnership with AcademicCME and ArcheMedX demonstrated how we can enhance the continuing education the CME community offers to healthcare providers throughout the US and abroad, and we are thrilled to now support the lifelong learning of oncologists and urologists in increasingly effective and efficient ways,” commented Sandy Breslow, Director of the EOCME.
According to learning outcomes data released earlier this year, paired analysis of pre- and post-lesson assessment data shows that learners participating in the Multiple Sclerosis education consistently and repeatedly improved learning, competency, and performance including a 68% increase in knowledge change between their pre-test and the first time they attempted their post-test.
As Dr. Timothy Hayes, President of AcademicCME, explains, “Learners continue to look to Elsevier’s Office of Continuing Medical Education for world-class CE that simplifies lifelong learning and, with the proven success of the ArcheViewer, we believe that the rapidly changing fields of Oncology and Urology are a natural next step for the more interactive and engaging educational experience we are delivering together.”
Clinicians who participate in either educational series will engage in content developed by world-class faculty and leverage a structured set of learning tools (powered by the ArcheViewer) that enable each learner to:
– archive relevant lessons to their personal ‘learning stream’;
– take and synchronize notes at any moment during the lesson;
– set critical reminders that prompt the learners to reflect and apply what they have learned over time,
– search through and review resources (i.e., articles, studies, tools) selected by faculty; and,
– submit questions directly to faculty
Access to these two new initiatives, “Emerging Science and Therapies in Lung Cancers” (for Oncologists) and “Strategies to Improve Outcomes in Patients with Overactive Bladder” (for Primary Care Physicians and Urologists) is now available for Elsevier’s registered learners. To learn more about these pioneering CME programs please contact Sandy Breslow at S.Breslow@elsevier.com or Dr. Timothy Hayes at thayes@academicCME. For additional information on the ArcheMedX e-learning delivery and assessment solutions, including the ArcheViewer e-learning platform, please contact Joel Selzer, CEO of ArcheMedX, at email@example.com.
AcademicCME is a physician-run, healthcare solutions medical education company designed to impact practice behavior and thus patient outcomes. AcademicCME leadership draws on the more than 45 years of clinical experience of its staff physicians in clinical practice and education, which provides a unique understanding of the dynamics between physician behavior, patient care and practice based educational needs. Visit www.academiccme.com for more information.
ArcheMedX is a healthcare informatics and e‐learning technology company with the singular mission to build the structure required to transform medical education through new connected learning and assessment models. By engineering an informatics‐powered architecture that organizes and connects the natural learning actions of clinicians in one system, ArcheMedX simplifies lifelong learning and streamlines the process of educational planning, assessment and support. Visit www.archemedx.com for more information.
About Elsevier and the Elsevier Office of CME
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). The mission of the Elsevier Office of CME is to plan, develop and implement educational interventions that align with the needs of health care providers to improve clinical competence, performance, and measurable patient outcomes. Visit www.elseviercme.com for more information.